Transmitted/Founder and Chronic HIV-1 Envelope Proteins Are Distinguished by Differential Utilization of CCR5
出版年份 2012 全文链接
标题
Transmitted/Founder and Chronic HIV-1 Envelope Proteins Are Distinguished by Differential Utilization of CCR5
作者
关键词
-
出版物
JOURNAL OF VIROLOGY
Volume 87, Issue 5, Pages 2401-2411
出版商
American Society for Microbiology
发表日期
2012-12-27
DOI
10.1128/jvi.02964-12
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Macrophage-tropic HIV-1 variants from brain demonstrate alterations in the way gp120 engages both CD4 and CCR5
- (2012) Hamid Salimi et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin α4β7
- (2012) Nicholas F. Parrish et al. PLoS Pathogens
- Presence of CXCR4-Using HIV-1 in Patients With Recently Diagnosed Infection: Correlates and Evidence for Transmission
- (2011) Kristen Chalmet et al. JOURNAL OF INFECTIOUS DISEASES
- Primary Infection by a Human Immunodeficiency Virus with Atypical Coreceptor Tropism
- (2011) C. Jiang et al. JOURNAL OF VIROLOGY
- Phenotypic and Immunologic Comparison of Clade B Transmitted/Founder and Chronic HIV-1 Envelope Glycoproteins
- (2011) C. B. Wilen et al. JOURNAL OF VIROLOGY
- Generation of Transmitted/Founder HIV-1 Infectious Molecular Clones and Characterization of Their Replication Capacity in CD4 T Lymphocytes and Monocyte-Derived Macrophages
- (2011) C. Ochsenbauer et al. JOURNAL OF VIROLOGY
- Dose-response curve slope is a missing dimension in the analysis of HIV-1 drug resistance
- (2011) M. E. S. Sampah et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HIV-1 predisposed to acquiring resistance to maraviroc (MVC) and other CCR5 antagonists in vitro has an inherent, low-level ability to utilize MVC-bound CCR5 for entry
- (2011) Michael Roche et al. Retrovirology
- Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections
- (2011) S. Gnanakaran et al. PLoS Pathogens
- Protection of Rhesus Macaques from Vaginal Infection by Vaginally Delivered Maraviroc, an Inhibitor of HIV‐1 Entry via the CCR5 Co‐Receptor
- (2010) Ronald S. Veazey et al. JOURNAL OF INFECTIOUS DISEASES
- A Maraviroc-Resistant HIV-1 with Narrow Cross-Resistance to Other CCR5 Antagonists Depends on both N-Terminal and Extracellular Loop Domains of Drug-Bound CCR5
- (2010) John C. Tilton et al. JOURNAL OF VIROLOGY
- A Conserved Determinant in the V1 Loop of HIV-1 Modulates the V3 Loop To Prime Low CD4 Use and Macrophage Infection
- (2010) T. Musich et al. JOURNAL OF VIROLOGY
- Wide Variation in the Multiplicity of HIV-1 Infection among Injection Drug Users
- (2010) K. J. Bar et al. JOURNAL OF VIROLOGY
- An altered and more efficient mechanism of CCR5 engagement contributes to macrophage tropism of CCR5-using HIV-1 envelopes
- (2010) Jasminka Sterjovski et al. VIROLOGY
- High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men
- (2010) Hui Li et al. PLoS Pathogens
- Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection
- (2009) Jesus F. Salazar-Gonzalez et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission
- (2009) Manish Sagar et al. JOURNAL OF INFECTIOUS DISEASES
- A Quantitative Affinity-Profiling System That Reveals Distinct CD4/CCR5 Usage Patterns among Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus Strains
- (2009) Samantha. H. Johnston et al. JOURNAL OF VIROLOGY
- Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants
- (2009) M.-R. Abrahams et al. JOURNAL OF VIROLOGY
- Resistance to CCR5 inhibitors caused by sequence changes in the fusion peptide of HIV-1 gp41
- (2009) C. G. Anastassopoulou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inefficient entry of vicriviroc-resistant HIV-1 via the inhibitor-CCR5 complex at low cell surface CCR5 densities
- (2009) Pavel Pugach et al. VIROLOGY
- A pièce de resistance: how HIV-1 escapes small molecule CCR5 inhibitors
- (2009) John P Moore et al. Current Opinion in HIV and AIDS
- Inflammatory Genital Infections Mitigate a Severe Genetic Bottleneck in Heterosexual Transmission of Subtype A and C HIV-1
- (2009) Richard E. Haaland et al. PLoS Pathogens
- Phase II Study of Vicriviroc versus Efavirenz (both with Zidovudine/Lamivudine) in Treatment‐Naive Subjects with HIV‐1 Infection
- (2008) Raphael J. Landovitz et al. JOURNAL OF INFECTIOUS DISEASES
- Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing
- (2008) J. F. Salazar-Gonzalez et al. JOURNAL OF VIROLOGY
- Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs
- (2008) Lin Shen et al. NATURE MEDICINE
- Maraviroc for Previously Treated Patients with R5 HIV-1 Infection
- (2008) Roy M. Gulick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection
- (2008) B. F. Keele et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge
- (2008) Johanna Repits et al. VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started